Frontlight ResearchEarly access
Trial site
Hospital Universitari Quiron Dexeus Barcelona
- 4running trials
- 1closed trial
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer2 trials
- Gastric and oesophageal cancer1 trial
- Lung cancer1 trial
- Metastatic breast cancer1 trial
- Prostate cancer1 trial
- Uterine fibroids1 trial
- Phase
- Phase 11 trial
- Phase 1/21 trial
- Phase 21 trial
- Phase 31 trial
- Status
- Not yet recruiting3 trials
- Active, not recruiting1 trial
- Completed1 trial
- Lead sponsor
- Eli Lilly and Company2 trials
- Amgen1 trial
- Daiichi Sankyo1 trial
- PregLem SA1 trial
Running trials
Not yet recruiting
Recruiting
Recruiting
Active, not recruiting
Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer2 recruiting
- Gastric and oesophageal cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Prostate cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 15 Nov 2026